Stonepine Capital Management, LLC Catalyst Biosciences, Inc. Transaction History

Stonepine Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $2.4 Million - $11 Million	-2,635,014 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.78 - $5.18 $1.67 Million - $2.29 Million	-441,362 Reduced 14.35%	2,635,014 $10.8 Million
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $2.57 Million - $3.34 Million	626,183 Added 25.56%	3,076,376 $13.3 Million
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $7.97 Million - $11.6 Million	1,615,744 Added 193.63%	2,450,193 $12.3 Million
Q4 2020 Feb 12, 2021	SELL	$4.55 - $7.29 $2.63 Million - $4.21 Million	-576,963 Reduced 40.88%	834,449 $5.27 Million
Q3 2020 Nov 13, 2020	BUY	$4.22 - $6.04 $3.65 Million - $5.22 Million	863,871 Added 157.77%	1,411,412 $6.07 Million
Q2 2020 Aug 13, 2020	SELL	$3.76 - $8.01 $1.77 Million - $3.78 Million	-471,655 Reduced 46.28%	547,541 $3.21 Million
Q1 2020 May 14, 2020	BUY	$3.5 - $8.51 $2.49 Million - $6.06 Million	711,909 Added 231.68%	1,019,196 $4.45 Million
Q4 2019 Feb 13, 2020	BUY	$4.52 - $7.91 $1.39 Million - $2.43 Million	307,287 New	307,287 $2.09 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.